Lipid Panel Testing Market Poised to Hit $16.27 Billion by 2029 with Accelerating Growth Trends

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Lipid Panel Testing Market Size Growth Forecast: What to Expect by 2025?
There has been a substantial growth in the lipid panel testing market size in the past few years. The market is anticipated to expand from $10.88 billion in 2024 to an impressive $11.61 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.7%. Factors contributing to this expansion during this historical period are an increase in cardiovascular diseases, better understanding and promotion of preventive healthcare, governmental measures advocating cardiovascular health, lifestyle modifications and changes in diet, along with an aging population and the prevalence of chronic diseases.

How Will the Lipid Panel Testing Market Size Evolve and Grow by 2029?
The market size for lipid panel testing is set to experience solid expansion in the upcoming years, with projections indicating a growth to a value of $16.27 billion by 2029, at a compound annual growth rate (CAGR) of 8.8%. Factors contributing to this forecasted growth include the rise in genetic testing and personalized treatments, increased emphasis on early diagnosis and prevention, a surge in home testing kits, a shift towards value-based care, and greater screening efforts amongst high-risk groups. Key trends to look out for in this growth period encompass point-of-care tests, electronic health record integration, genetic lipid tests, home testing kits, inclusion of telemedicine, and educational interventions aimed at lipid control.

View the full report here:
https://www.thebusinessresearchcompany.com/report/lipid-panel-testing-global-market-report

What Drivers Are Propelling the Growth of Lipid Panel Testing Market Forward?
The growth of the lipid panel testing market is anticipated to be fueled by the escalating incidents of cardiovascular and diabetic illnesses. Cardiovascular diseases impact the health of heart and blood vessels, while diabetes, a metabolic disease, disrupts the body's insulin production leading to elevated blood sugar levels. Lipid panel testing serves as a crucial tool for diagnosing those at an increased risk of developing cardiovascular diseases or those who are already affected. It also aids in tracking the treatment efficiency of individuals already affected by cardiovascular or diabetes diseases, enabling healthcare practitioners to modify treatment strategies as needed to reach the desired lipid levels and mitigate further health risks. For instance, the World Health Organization, a specialized agency of the United Nations based in Switzerland, reported in September 2023 that there had been 17.9 million fatalities from cardiovascular diseases. Moreover, the Centers for Disease Control and Prevention's (CDC) National Diabetes Statistics Report, a government agency based in the US, recorded a surge in diabetes cases in the US reaching 37.3 million in 2022. As a result, efforts to combat cardiovascular and diabetic diseases will propel the lipid panel testing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10270&type=smp

Which Emerging Trends Are Transforming the Lipid Panel Testing Market in 2025?
The emergence of product innovations is a prominent trend observed in the lipid panel testing market. The leading firms in this market are concentrating on the creation of novel products to ensure their market dominance. To illustrate, the US biotech firm, Boston Heart Diagnostics, launched a new product called LipoMap in October 2022. This product, containing a panel of 33 lipid, lipoprotein, and apolipoprotein tests, provides one of the most thorough commercial assessments of lipid metabolism. LipoMap identifies treatable and reversible lipid abnormalities that lead to cardiovascular disease (CVD), paving the way for enhanced customization in treatment and subsequent testing.

What Are the Key Segments in the Lipid Panel Testing Market?
The lipid panel testing market covered in this report is segmented -

1) By Product And Services: Devices, Kits, Services
2) By Prescription Mode: Prescription-Based Testing, OTC-Based Testing
3) By Application: Hyperlipidemia, Hypertriglyceridemia, Familial Hypercholesterolemia, Hypo-Lipoproteinemia, Tangier Disease, Atherosclerosis, Other Applications
4) By End User: Hospital, Specialty Clinics And Physician Offices, Pathology Laboratories, Diagnostic Clinics, Ambulatory Surgical Centers, Reference Laboratories, Academic And Research Institutes, Other End-Users

Subsegments:
1) By Devices: Automated Analyzers, Point-Of-Care Testing Devices, Spectrophotometers
2) By Kits: Test Kits For Cholesterol, HDL And LDL Kits, Triglyceride Test Kits
3) By Services: Laboratory Testing Services, Diagnostic Services, Health Screening Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10270&type=smp

Who Are the Key Players Shaping the Lipid Panel Testing Market's Competitive Landscape?
Major companies operating in the lipid panel testing market include Abbott Laboratories, Beckman Coulter Inc., F. Hoffmann-La Roche Ltd., Randox Laboratories Ltd., Thermo Fisher Scientific Inc., PTS Diagnostics, Quest Diagnostics Incorporated, Alere Inc., EuroMedix International, Boston Heart Diagnostics Corporation, Eurofins Scientific SE, Spark Diagnostics Pvt Ltd., Everlywell Inc., Horiba ABX SAS, Siemens Healthcare GmbH, Nova Biomedical Corporation, Bio-Rad Laboratories Inc., Danaher Corporation, DiaSorin S.p.A., EKF Diagnostics Holdings plc, Grifols S.A., Hologic Inc., Luminex Corporation, Meridian Bioscience Inc., Ortho Clinical Diagnostics LLC

What Geographic Markets Are Powering Growth in the Lipid Panel Testing Market?
North America was the largest region in the lipid panel testing market in 2024. Asia-Pacific is expected to be the fastest growing region in the global lipid panel testing market during the forecast period. The regions covered in the lipid panel testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10270

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.